Gujarat Terce Laboratories Stock Price - ₹37.50 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Gujarat Terce Laboratories Stock Price - ₹37.50 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q3 FY19	Q4 FY19	Q1 FY20	Q2 FY20	Q3 FY20	Q4 FY20	Q1 FY21	Q2 FY21	Q1 FY22	Q2 FY22
Sales	8.31	8.02	6.94	11.15	10.11	9.34	4.98	7.2	9.94	10.13
Expenses	7.64	7.89	8.05	9.31	9.66	9.84	5.38	7.09	8.31	9.59
EBITDA	0.67	0.13	-1.11	1.84	0.45	-0.5	-0.4	0.11	1.63	0.54
Depreciation	0.05	0.06	0.05	0.06	0.06	0.07	0.06	0.04	0.05	0.05
EBIT	0.62	0.07	-1.16	1.78	0.39	-0.57	-0.46	0.07	1.58	0.49
Interest	0.05	0.1	0.05	0.1	0.04	0.1	0.05	0.17	0.05	0.1
Profit Before Tax	0.57	-0.03	-1.21	1.68	0.35	-0.67	-0.51	-0.1	1.53	0.39
Net Profit	0.57	0.36	-1.22	1.69	0.37	-0.57	-0.44	-0.02	1.6	0.45
EPS	0.77	0.49	0	2.28	0.5	0	-0.6	-0.02	2.16	0.61

Cashflow

Standalone₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Operating Cash Flow	1.38	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03	2.6	3.06	1.71
Investing Cash Flow	0.08	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-0.87	0.62	-0.46	0.46	-0.11
Financing Cash Flow	-0.73	-1.43	-0.36	-5.39	0.2	1.72	1.83	1.53	-0.12	-4.08	-2.83	0.47
Net Cash Flow	0.73	-1.4	0.06	0.3	-0.54	-0.14	1.25	0.22	0.53	-1.94	0.69	2.07

Balance Sheet

AnnualStandalone₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Equity / Shareholders' Funds	11.03	10.36	10.06	10.4	10.83	11.11	7.66	8.53	6.86	7.11	6.48	9.73
Total Liabilities	15.27	14.11	13.6	9.06	8.5	11.4	14.21	18.86	21.66	16.17	16.35	14.82
Total Assets	26.3	24.47	23.66	19.47	19.34	22.51	21.87	27.39	28.53	23.27	22.83	24.55

Shareholding

₹30 CrMarket Cap

Promoter & promoter group (40.03%)

Public & others (59.97%)